表紙:米国の整形外科用バイオマテリアル市場・COVID19-の影響 (2019-2025年):MedSuite
市場調査レポート
商品コード
1000911

米国の整形外科用バイオマテリアル市場・COVID19-の影響 (2019-2025年):MedSuite

U.S. Orthobiologics Market Analysis - COVID19 - 2019-2025 - MedSuite - Includes: Bone Graft Substitutes, Cellular Allografts, Growth Factors, Orthopedic Cell Therapy, Hyaluronic Acid Viscosupplementation & Orthopedic Cartilage Repair Devices

出版日: | 発行: iData Research Inc. | ページ情報: 英文 478 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円

※ Single Userライセンスは、DRM (デジタル著作権管理システム) 付PDFになります。
認証されたPC上のみでの閲覧となっております。

米国の整形外科用バイオマテリアル市場・COVID19-の影響 (2019-2025年):MedSuite
出版日: 2021年03月19日
発行: iData Research Inc.
ページ情報: 英文 478 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

米国の整形外科用バイオマテリアルの市場規模は2020年の31億米ドルから、2025年には50億米ドル超の規模に成長すると予測されています。

当レポートでは、米国の整形外科用バイオマテリアルの市場を調査し、市場概要、市場成長推進因子・抑制因子、製品ポートフォリオ、臨床試験の動向、市場規模・販売数・ASPの推移・予測、製品区分別の詳細分析、競合分析、企業シェア、企業および企業間の展開などをまとめています。

目次

図のリスト

チャートのリスト

エグゼクティブサマリー

米国の整形外科用バイオマテリアル市場:市場概要

競合分析

市場動向

市場の発展

処置件数

対象市場

更新

改訂履歴

調査手法

COVID-19の影響

製品評価

  • 製品ポートフォリオ
  • 規制上の問題・リコール
  • 臨床試験

米国の整形外科用バイオマテリアル市場:市場概要

  • 市場概要
  • 市場分析・予測:区分別
    • 代替骨移植片
    • 骨成長因子
    • 細胞同種移植片
    • 細胞治療
    • ヒアルロン酸(HA)関節内補充
    • 軟骨修復
  • 成長推進因子・抑制因子
  • 市場シェア分析
  • M&A
  • 企業プロファイル
    • Anika Therapeutics
    • Bioventus
    • DePuy Synthes
    • Ferring Pharmaceuticals
    • Fidia Pharmaceuticals
    • Genzyme (Sanofi Group)
    • Harvest Technologies (Terumo BCT) Integra LifeSciences
    • Medtronic
    • Musculoskeletal Transplant Foundation (MTF)
    • NuVasive
    • Orthofix
    • RTI Surgical
    • Stryker
    • Vericel Corporation (formerly Aastrom Bioscience)
    • Zimmer Biomet
  • SWOT分析

処置件数

整形外科用代替骨移植片市場の分析・予測

  • 市場概要
  • 市場分析・予測:区分別
  • 成長推進因子・抑制因子
  • 市場シェア分析

整形外科用骨成長因子市場の分析・予測

  • 市場概要
  • 市場分析・予測:区分別
  • 成長推進因子・抑制因子
  • 市場シェア分析

細胞同種移植片市場の分析・予測

  • 市場概要
  • 市場分析・予測:区分別
  • 成長推進因子・抑制因子
  • 市場シェア分析

整形外科細胞治療市場の分析・予測

  • 市場概要
  • 市場分析・予測:区分別
  • 成長推進因子・抑制因子
  • 市場シェア分析

ヒアルロン酸関節内補充療法市場の分析・予測

  • 市場概要
  • 市場分析・予測:区分別
  • 成長推進因子・抑制因子
  • 市場シェア分析

整形外科軟骨修復市場の分析・予測

  • 市場概要
  • 市場分析・予測:区分別
  • 成長推進因子・抑制因子
  • 市場シェア分析

略語

目次
Product Code: iDATA_USOB19_MS

Throughout this medical market research, the publisher analyzed 47+ Orthobiologics companies in the United States and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this report suite report contains all of the U.S. Orthobiologics market analysis, each of the market segments is also available as a stand-alone a report, MedCore.

Markets Covered

  • Bone Graft Substitutes Market - MedCore
  • Growth Factors Market - MedCore
  • Cellular Allografts Market - MedCore
  • Orthopedic Cell Therapy Devices Market - MedCore
  • Hyaluronic Acid Viscosupplementation Devices Market - MedCore
  • Orthopedic Cartilage Repair Devices Market - MedCore

U.S. Orthobiologics Market Insights

Overall, the U.S. orthopedic biomaterials market was valued at $3.1 billion in 2020. This is expected to increase over the forecast period to reach over $5 billion in 2025.

A particular trend in the U.S. orthopedic biomaterials market is competitors that are seeking to penetrate high-growth segments outside their traditional space by distributing existing products manufactured by other companies, rather than creating their own. This often involves partnering with a company by taking on the costs associated with regulation and market approval, in exchange for exclusive market rights. The distributor then pays the manufacturer in royalties. The goal is to penetrate the high-growth segments and build or strengthen networks before the segment matures. This is especially the case for competitors in segments that are in decline, such as competitors in the five-injection hyaluronic acid treatment.

Medtronic leads the U.S. orthopedic biomaterials market. They have the largest share in the bone graft substitute segment and had their dominating product, INFUSE™ in the growth factor market. This company's growth has been recovering since the negative media attention and lawsuits regarding off-label usage of its growth factor bone morphogenetic protein (BMP) product, INFUSE®, which accounts for a significant portion of the company's revenue in biologic therapy.

TABLE OF CONTENT

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

IMPACT OF COVID-19 ON THE U.S. ORTHOPEDIC BIOMATERIALS MARKET

  • 2.1 INTRODUCTION

Treatable Population and the SARS-CoV-2 Virus

  • 2.2 ANALYSIS BY MARKET SEGMENT

Best Case Scenario

Base Case Scenario

Worst Case Scenario

PRODUCT ASSESSMENT

  • 3.1 INTRODUCTION
  • 3.2 PRODUCT PORTFOLIOS

Bone Graft Substitutes

Growth Factors

Other products

Cellular Allografts (Stem Cell)

Cell Therapy

Platelet-Rich Plasma

Concentrated Bone Marrow Aspirate

Hyaluronic Acid Viscosupplementation (HAV)

Cartilage Repair

  • 3.3 REGULATORY ISSUES AND RECALLS

Bone Graft Substitutes

Allografts

MTF

DBM

AlloSource

SeaSpine

RTI Surgical

Synthetics

Abyrx

Zimmer Biomet

Growth Factors

Medtronic

Cell Therapy

Bone Marrow Cell Therapy

Argon Medical Devices

Stryker

Teleflex

Hyaluronic Acid Viscosupplementation

Three-injection

Ferring Pharmaceuticals

Cartilage Repair

Smith & Nephew

Richard Wolf

  • 3.4 CLINICAL TRIALS

Bone Graft Substitutes

Allografts

Providence Medical Technology

The University of Texas Health Science

University of Winchester

BDM

K2M

Zimmer Biomet

Synthetics

Baxter

Bonesupport

DePuy Synthes

NuVasive

RTI surgical

Sunstar GUIDOR

Other materials and comparison

Seoul National University Hospital.

Sewon Cellontech

SurgaColl Technologies Limited

University of Colorado

TABLE OF CONTENTS

© iData Research Inc., 2019 iv

University of Padova

Growth Factors

Bioventus

Cerapedics

CGBio

Isto

Medtronic

NuVasive

Wright

Others

Cellular Allografts (Stem Cell)

Cervical

DePuy Synthes

Virginia Spine Institute

Lumbar

RTI Surgical

Trinity Stem Cell Institute

Spinal Cord

AFBMTC

Stem Cells Arabia

Pharmicell

Knee, Foot, Ankle, Tibial

Medipost

Nantes University Hospital

Royan Institute

Red de Terapia Celular

RTI Surgical

University of Jordan

Cell Therapy

Bone Marrow Cell Therapy

Centre of Postgraduate Medical Education

New York University

TABLE OF CONTENTS

© iData Research Inc., 2019 v

Stempeutics Research

Royan Institute

Universidad Autonoma de Madrid

Vericel (Aastrom Bioscience)

Platelet-Rich Cell Therapy

Assistance Publique Hopitaux De Marseille

Assiut University

Brian Walters

Hospital for Special Surgery

Istituto Ortopedico Rizzoli

Rio de Janeiro State University

Tri-Service General Hospital

University of California

Others

Hyaluronic Acid Viscosupplementation

Anika Therapeutics

Bioventus

Cario University

Ferring Pharmaceuticals

Federal University of Minas Gerais

Fidia Pharma USA Inc.

Istituto Ortopedico Rizzoli

University Hospital

Universidade Nova de Lisboa

Cartilage Repair

Autologous Chondrocyte Implantation

BioGend (Exactech)

Histogenics

ISTO and Zimmer Biomet

Shetty-Kim Research Foundation

Meniscal Allograft

Orthox

Microfracture Adjunct

Anika Therapeutics

Aesculap Biologics

Sewon Cellontech

Smith & Nephew

Osteochondral Allograft

TBF Genie Tissulaire

Particulated Juvenile Cartilage

Zimmer Biomet

U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

  • 4.1 INTRODUCTION

Bone Graft Substitutes

Growth Factors

Cellular Allografts

Cell Therapies

Hyaluronic Acid (HA) Viscosupplementation

Cartilage Repair

  • 4.2 MARKET OVERVIEW
  • 4.3 TREND ANALYSIS BY SEGMENT
  • 4.4 DRIVERS AND LIMITERS

Market Drivers

Market Limiters

  • 4.5 COMPETITIVE MARKET SHARE ANALYSIS
  • 4.6 MERGERS AND ACQUISITIONS
  • 4.7 COMPANY PROFILES

Anika Therapeutics

Bioventus

DePuy Synthes

Ferring Pharmaceuticals

Fidia Pharmaceuticals

Genzyme (Sanofi Group)

Harvest Technologies (Terumo BCT)

Integra LifeSciences

Medtronic

Musculoskeletal Transplant Foundation (MTF)

NuVasive

Orthofix

RTI Surgical

Stryker

Vericel Corporation (formerly Aastrom Bioscience)

Zimmer Biomet

  • 4.8 SWOT ANALYSIS

Anika Therapeutics

Bioventus

DePuy Synthes

Ferring Pharmaceuticals

Fidia Pharmaceuticals

Harvest Technologies (Terumo BCT)

Integra LifeSciences

Medtronic

Musculoskeletal Transplant Foundation (MTF)

NuVasive

Orthofix

Stryker

Vericel Corporation (formerly Aastrom Bioscience)

Zimmer Biomet

PROCEDURE NUMBERS

  • 5.1 INTRODUCTION
  • 5.2 PROCEDURES

Total Orthopedic Biomaterial Procedures by Segment

Orthopedic Bone Grafting Procedures

Orthopedic Bone Grafting Procedures by Material

Autograft Procedures by Indication

Allograft Procedures by Indication

DBM Procedures by Indication

Synthetic Procedures by Indication

Orthopedic Bone Grafting Procedures by Indication

Average Units Used per Procedure by Indication

Orthopedic Growth Factor Procedures

Orthopedic Growth Factor Procedures by Indication

Cellular Allograft Procedures

Cellular Allograft Procedures by Anatomy

Orthopedic Cell Therapy Procedures

Orthopedic Cell Therapy Procedures by Type

Platelet-Rich Plasma Procedures by Indication

Bone Marrow Aspirate Concentrate Procedures by Indication

Hyaluronic Acid Supplementation Procedures

Hyaluronic Acid Supplementation Procedures by Injection Cycle

Orthopedic Cartilage Repair Procedures

Orthopedic Cartilage Repair Procedures by Type

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET

  • 6.1 INTRODUCTION

Units per Procedure by Indication

  • 6.2 MARKET OVERVIEW

Orthopedic Bone Graft Substitute Market by Material

Orthopedic Bone Graft Substitute Market by Indication

  • 6.3 MARKET ANALYSIS AND FORECAST

Orthopedic Bone Graft Substitute Market by Material

Total Allograft Bone Graft Substitute Market

Allograft Bone Graft Substitute Market by Indication

Total Demineralized Bone Matrix Allograft Bone Graft Substitute Market

DBM with Carriers Market

DBM without Carriers Market

Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication

Total Synthetic Bone Graft Substitute Market

Synthetic Bone Graft Substitute Market by Indication

Orthopedic Bone Graft Substitute Market by Indication

Spine Bone Graft Substitute Market

Cervical Spine Bone Graft Substitute Market

Thoracolumbar Spine Bone Graft Substitute Market

Trauma Bone Graft Substitute Market

Non-Union Trauma Bone Graft Substitute Market

Fresh Fracture Trauma Bone Graft Substitute Market

Large Joint Reconstruction Bone Graft Substitute Market

Hip Reconstruction Bone Graft Substitute Market

Knee Reconstruction Bone Graft Substitute Market

Foot Reconstruction Bone Graft Substitute Market

Craniomaxillofacial Bone Graft Substitute Market

Oncology Bone Graft Substitute Market

  • 6.4 DRIVERS AND LIMITERS

Allograft Market

Market Drivers

Market Limiters

Demineralized Bone Matrix Bone Graft Substitute Market

Market Drivers

Market Limiters

Synthetic Bone Graft Substitute Market

Market Drivers

Market Limiters

  • 6.5 COMPETITIVE MARKET SHARE ANALYSIS

ORTHOPEDIC GROWTH FACTOR MARKET

  • 7.1 INTRODUCTION

BMP-2 (Medtronic)

PDGF-BB (Wright Medical)

BMP-7 (Ember Therapeutics)

P-15 Synthetic Small Peptide (Cerapedics)

  • 7.2 MARKET ANALYSIS AND FORECAST
  • 7.3 DRIVERS AND LIMITERS

Market Drivers

Market Limiters

  • 7.4 COMPETITIVE MARKET SHARE ANALYSIS

CELLULAR ALLOGRAFT MARKET

  • 8.1 INTRODUCTION

Lineage

Human Embryonic Stem Cells (hESC)

Mesenchymal Stem Cells (MSC)

Other Therapeutic Applications

  • 8.2 MARKET OVERVIEW
  • 8.3 MARKET ANALYSIS AND FORECAST

Total Cellular Allograft Market

Cervical Spine Cellular Allograft Market

Lumbar Spine Cellular Allograft Market

  • 8.4 DRIVERS AND LIMITERS

Market Drivers

Market Limiters

  • 8.5 COMPETITIVE MARKET SHARE ANALYSIS

ORTHOPEDIC CELL THERAPY MARKET

  • 9.1 INTRODUCTION
  • 9.2 MARKET OVERVIEW
  • 9.3 MARKET ANALYSIS AND FORECAST

Platelet-Rich Plasma Market

Soft Tissue Platelet-Rich Plasma Market

Orthopedic Platelet-Rich Plasma Market

Cardiac Platelet-Rich Plasma Market

Spine Platelet-Rich Plasma Market

Plastics Platelet-Rich Plasma Market

Bone Marrow Aspirate Concentrate Market

Spine Bone Marrow Aspirate Concentrate Market

Trauma Bone Marrow Aspirate Concentrate Market

Orthopedic Soft Tissue Bone Marrow Aspirate Concentrate Market

Joint Reconstruction Bone Marrow Aspirate Concentrate Market

  • 9.4 DRIVERS AND LIMITERS

Market Drivers

Market Limiters

  • 9.5 COMPETITIVE MARKET SHARE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 10.1 INTRODUCTION

Benefits of Viscosupplementation

Synovial Fluid

Product Types

Single-Injection Products

Two-Injection Cycle Products

Three-Injection Cycle Products

Three/Five-Injection Cycle Products

Reimbursement

  • 10.2 MARKET OVERVIEW
  • 10.3 MARKET ANALYSIS AND FORECAST

Total Hyaluronic Acid Viscosupplementation Market

Single-Injection Hyaluronic Acid Viscosupplementation Market

Two-Injection Hyaluronic Acid Viscosupplementation Market

Three-Injection Hyaluronic Acid Viscosupplementation Market

Five-Injection Hyaluronic Acid Viscosupplementation Market

  • 10.4 DRIVERS AND LIMITERS

Market Drivers

Market Limiters

  • 10.5 COMPETITIVE MARKET SHARE ANALYSIS

ORTHOPEDIC CARTILAGE REPAIR MARKET

  • 11.1 INTRODUCTION

Anatomy

Methods for Cartilage Repair

Microfracture

Microfracture Adjunct

Osteoarticular Autograft Transfer System

Particulated Juvenile Allograft

Osteochondral Allograft Transfer

Autologous Chondrocyte Implantation

Meniscal Allograft Transplantation

  • 11.2 MARKET OVERVIEW
  • 11.3 MARKET ANALYSIS AND FORECAST

Osteochondral Allograft Market

Meniscal Allograft Market

Autologous Chondrocyte Implantation Market

Particulated Juvenile Allograft Market

Microfracture Adjunct Market

  • 11.4 DRIVERS AND LIMITERS

Market Drivers

Market Limiters

  • 11.5 COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS